Hansol Chemical한솔케미칼
014680 · KOSPI · ₩014680 · 한솔케미칼
What brokers say about Hansol Chemical
Calculated by JONBUR from publicly available broker reports. Reports belong to their publishers. Not financial advice. Includes brokers that publish research publicly; some brokers' reports are client-only and not included.
AI summary of public information
An AI summary of the public information on this company: filed financial statements, filings, prices and news headlines. It doesn't use broker reports; their targets and estimates are shown above.
Hansol Chemical's first-half 2026 profits remain solid, but the shares are down sharply over the past year and trade well below their 52-week high.
Hansol Chemical makes fine chemicals for semiconductors and displays, along with paper and environmental products. On trailing figures to H1 2026 it reports revenue of ₩932B, operating income of ₩160B and a 17.2% operating margin. The share price of ₩204,000 sits far below its 52-week high of ₩346,500, and the data's discounted cash flow base value of ₩125,958 is well under the current price.
What stands out
- Trailing revenue of ₩932B is above the 2025 full-year figure of ₩884B, and trailing net income of ₩154B is close to 2025's ₩147B.
- Annual operating margin has eased from 25.7% in 2021 to 17.7% in 2025 and 17.2% on trailing figures.
- Borrowings of ₩302B exceed cash of ₩97B, while liabilities are 38.4% of equity; free cash flow over the trailing period was ₩125B.
- Shares are down 13.7% over one month, 9.5% over three months and 4% over one year, while foreign ownership rose from 40.4% to 42.1% over 60 days.
- Valuation is P/E 14.3 and P/B 2.0, with a 1.3% dividend yield; the data's own fair-value model gives a bear-to-bull range of ₩73,985 to ₩209,290.
What to watch
- Full-year 2026 results and any change to the margin trend seen since 2021.
- Further filings on large shareholder and 5%+ holding changes, which have been frequent since late July.
- Recent investor flows were net selling by foreign investors (−₩42B) and retail investors (−₩25B) over 20 days, offset by institutional buying (+₩67B); the data does not name specific risks beyond these figures.
Data as of Oct 26, 2026 · written yesterday
This is not financial advice.
Also known as: Hansol Chemical / 한솔케미칼 / 014680 / KRX:014680
Source: KRX statistical information